8-K: Optimus Healthcare Services Faces Imminent Default as Forbearance Period Expires, Liquidity Dwindles

Optimus Healthcare Services, Inc. announced the expiration of its forbearance agreement, leaving it in default on senior secured convertible notes with insufficient cash to sustain operations beyond 60-90 days, prompting a review of strategic alternatives including potential bankruptcy.

Summary

• The forbearance period with Arena Investors, LP regarding senior secured convertible notes (May 2021 and June 2022 Notes) expired on April 30, 2025.
• Optimus Healthcare Services, Inc. (the Company) has not cured the Specified Defaults, giving Purchasers the right to accelerate the Notes.
• The Company has approximately $251,000 in cash and cash equivalents as of June 6, 2025, which management believes is insufficient to continue operations beyond the next 60-90 days.
• The Company has been unable to raise additional new capital from investors since the forbearance period expired.
• The Company is evaluating strategic alternatives, including financing options, sale of the Company or assets, wind down, or seeking bankruptcy protection.
• A cost-reduction plan will be implemented while the strategic review is ongoing.

Sentiment

Score: 1

Explanation: The document indicates severe financial distress, expired forbearance, uncured defaults, insufficient liquidity, and a high risk of insolvency and inability to continue as a going concern, with no assurance of successful strategic alternatives.

Negatives

• The Forbearance Period expired on April 30, 2025, and the Company has not cured the Specified Defaults.
• Purchasers of senior secured convertible notes now have the right to accelerate and declare all or any portion of the Notes due and payable.
• The Company has no assurance that Purchasers will not seek to enforce their rights, which could lead to a material adverse effect on liquidity, financial condition, and results of operations, potentially rendering the Company insolvent and unable to continue as a going concern.
• Cash and cash equivalents of approximately $251,000 as of June 6, 2025, are insufficient to sustain operations beyond 60-90 days.
• The Company has been unable to raise additional new capital from investors since the forbearance period expired.
• A $2,000,000 subscription agreement for Preferred Stock and Warrants, with $500,000 received, is contingent on an extension of the Forbearance Period and an amendment to the Forbearance Agreement, which have not been received.
• An advance of $1,260,000 received on May 16, 2025, is subject to conditions (forbearance extension/amendment) that have not been met, and the investor required it to be transferred to an escrow account.

Risks

• Inability to satisfy obligations under outstanding indebtedness or accounts payables to suppliers.
• Uncertainty regarding the Company's ability to continue as a going concern.
• Inability to raise capital to fund operations.
• Potential material adverse effect on liquidity, financial condition, and results of operations if defaults are not resolved or notes are accelerated.
• Risk of insolvency and inability to sustain operations.
• No assurance that strategic review will result in a transaction.
• Additional or unforeseen effects from the global economic climate may amplify risks.

Future Outlook

The Company is actively evaluating a full range of strategic alternatives to maximize stakeholder value, including various financing options, the potential sale of the Company or its assets, a business wind-down, or seeking bankruptcy protection for reorganization or sale. A cost-reduction plan will be implemented in the interim. There is no assurance that any strategic review will result in a transaction or that the Company will be able to refinance, restructure, or repay its indebtedness or continue as a going concern.

Management Comments

• "The Company is currently continuing to work with the Purchasers to address the remaining obligations under the Notes, however, there can be no assurance that any such arrangements will ever materialize or be permissible or sufficient to cover any or all of the obligations under the Notes."
• "If the Company continues not to have sufficient liquidity to pay the principal and interest on the Notes, or the Company is unable to resolve the alleged defaults under the Notes, the foregoing would likely have a material adverse effect on the Companys liquidity, financial condition and results of operations, and will render the Company insolvent and unable to sustain its operations and continue as a going concern."
• "No assurance can be provided that the Company will be able to refinance, restructure or repay our indebtedness or to continue as a going concern."
• "Management believes [approximately $251,000 in cash] is not sufficient for the Company to continue its operations beyond the next approximate 60-90 days."
• "The Company will continue to evaluate strategic alternatives to maximize value for all stakeholders."
• "The Company has not set a timetable for completion of the evaluation process and does not intend to disclose further developments or guidance on the status of its review unless and until the Board of Directors has approved a specific course of action or determines that further disclosure is appropriate or required."

Industry Context

The document primarily focuses on the Company's severe internal financial distress and inability to meet debt obligations, rather than broader industry trends. It highlights the challenges faced by small healthcare service companies in securing financing and managing debt, especially when facing defaults and liquidity crises.

Corporate Governance

Related Party Transactions

• The amended subscription agreement requires the Company to invest $450,000 of proceeds in Rua Diagnostics, Inc. (RUA).
• RUA is an entity controlled by the Company's largest shareholder's family.
• A current Board member of Optimus Healthcare Services, Inc. is also a Board member of RUA.
• This investment required the consent of the Purchasers under the Notes, which has not been received.

Stakeholder Impact

• Shareholders: Significant dilution risk from warrants and preferred stock, potential loss of investment if the company becomes insolvent or seeks bankruptcy protection. Share price likely to decline sharply.
• Creditors (Note Purchasers): Have the right to accelerate debt, increasing pressure on the Company. Risk of not recovering full principal and interest if the Company becomes insolvent.
• Employees: High risk of job losses due to cost-reduction plans, potential wind-down, or bankruptcy.
• Customers/Suppliers: Potential disruption of services or payments if the Company's operations are curtailed or cease.

Next Steps

• Continue working with Purchasers to address remaining obligations under the Notes.
• Implement a cost-reduction plan.
• Continue evaluating strategic alternatives, including financing options, sale of the Company or its assets, a wind down of the business, or seeking bankruptcy protection.
• The Company does not intend to disclose further developments or guidance on the status of its review unless the Board approves a specific course of action or determines further disclosure is appropriate or required.

Key Dates

Recommendation

Keywords

Optimus Healthcare Services, 8-K, SEC filing, forbearance agreement, default, senior secured convertible notes, liquidity crisis, going concern, capital raise, strategic alternatives, bankruptcy, healthcare services, financial distress